Intermittent Levosimendan infusion according to the lion-heart protocol in advanced heart failure: first pilot experience in fragile patient

20 March 2026 (08:30 - 18:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Lorenzo Bonadiman

Verona Integrated University Hospital, Verona (Italy)

71 More presentations in this session

Presentation thumbnail

Multimodality imaging of the aortic root and ascending aorta: a comparative study of CTA and echocardiography

Mr G. Imperatore (Pisa, IT)

Abstract Slides

Presentation thumbnail

Impact of atrial fibrillation burden on heart failure device alerts and therapy delivery: insights from remote monitoring in an island-based heart failure cohor

Doctor I. Almeida (Ponta Delgada, PT)

Abstract Slides

Presentation thumbnail

Respiratory infections as triggers of acute cardiovascular complications: a case series of new-onset atrial fibrillation and heart failure

Doctor A. Akhtar (Waterford, IE)

Abstract Slides

Presentation thumbnail

Stabilizing the unstable: characterization of advanced heart failure patients under intermittent levosimendan therapy

Doctor R. Brandao (Amadora, PT)

Abstract Slides

Presentation thumbnail

Predictors of Levosimendan reinitiation in patients with advanced heart failure undergoing intermittent inotropic therapy- is the lung that important?

Doctor R. Brandao (Amadora, PT)

Abstract Slides

Access the full session

Session thumbnail

Poster session (1)

The Event

Event poster

ESC Acute CardioVascular Care 2026

20 March 2026 08:30 CET

You may be interested in

Congress Session

Acute heart failure therapies: from clinical trials to clinical practice

Congress Session

Devices in acute heart failure

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources